Wills Glaucoma Service Foundation Lighthouse

 

Staff

Support

Education

Searchlight

Research

Fellowship

Donations

Locations

Search

Links

Contact

Home

 

 

 

 

 

 

 

THE WORLD-WIDE EFFECTS  OF GLAUCOMA

 

Rohit Varma, MD, MPH

 

Cataract is the leading cause of Blindness in the world with over 30 million persons affected by it. The second leading cause in the past was trachoma. However, with improvements in prevention and treatment, trachoma is on the decline. In contrast, Glaucoma (Open-angle and Angle Closure) is currently the second leading cause of blindness and given the aging population in both the developed and developing world, the prevalence of Glaucoma is increasing. It is estimated, that in 2000, 66.8 million persons in the world have Glaucoma (Open angle and Angle Closure) and 7.6 million of them are bilaterally blind based primarily on visual acuity measurement. The level of disability associated with glaucoma due to unilateral blindness and peripheral field loss has not been evaluated carefully. This is particularly important since recent data suggest that restriction in activities of daily living and accidental falls are associated with visual field loss.

 

The following tables and figure provide some estimates of open angle glaucoma and angle closure glaucoma and are adapted from Elolia and Stokes (www.hc-sc.gc.ca/pphb-dgspsp/publicat/cdic-mcc/19-4/d_e.html). Age, gender and race/ethnicity specific data are also provided. These data have then been synthesized into worldwide estimates(2).

 

 

 

 

Table 1

Prevalence Rates of Open Angle Glaucoma in

Some Population-based Studies

 

Study
(Year)

Age group

N

No of
cases

Prevalence rate

 

 

 

 

 

Framingham, MA
(1973–1975)

52–85

2433

28

1.4

Roscommon, Ireland
(1990)

>50

2186

41

1.9

Casteldaccia, Italy
(before 1992)

>40

1062

13

1.2

Ponza, Italy
(1986)

>40

1034

26

2.5

Beaver Dam, WI
(1988–1990)

 

43–84

4926

104

2.1

Baltimore, MD
(1985–1988)

>40

White

Black

5308

2913

2395

132

32

100

2.5

1.1

4.2

Barbados
(1988–1992)

40–84, AC

4631

309

6.7

St. Lucia

>30

1679

147

8.8

Japan
(1988–1989)

>40

8126

213

2.6

Mongolia
(1995)

>40

942

5

0.5

Mamre, South Africa (1992)

>40

987

15

1.5

Blue Mountains, Australia

(1992–1994)

>49

3654

108

3.0

Andhra Pradesh, India (1998-2000)

 

>30

1399

27

1.62

Melbourne, Australia

>40

3271

72

2.2

 

Tucson, AZ

(1997-1999)

>40

4774

94

1.97

 

Table 2 Age-Specific Prevalence Rates of Open Angle Glaucoma

Study

 Age group 

Prevalence (%)

Baltimore, MD.    

   (European)

 

40–49

0.9

50–59

0.4

60–69

0.9

70–79

2.9

80+

2.2

Total

1.3

Baltimore, MD

     (African-

    American)

 

 

40–49

1.2

50–59

4.1

60–69

5.5

70–79

9.2

80+

11.3

Total

4.7

 

Barbados

 

40–49

 

1.4

50–59

4.1

60–69

6.7

70–79

14.8

80+

23.2

Total

6.8

 

Andhra Pradesh, India

30-39

0.22

40-49

1.26

50-59

2.31

60-69

4.89

70+

6.32

Total

1.62

 

Tucson, AZ

41-49

0.5

50-59

0.59

60-69

1.73

70-79

5.66

80-89

12.02

90+

20

Total

1.97

 

Japan

30–49

1.0

50–69

2.6

70+

5.3

Total                  2.5

 

TABLE 3

Prevalence of primary angle-closure glaucoma

Study
(Year)

Age
group

N

No of
cases

Crude
prevalence
(%)

Beaver Dam, US
(1988–1990)

43–84

4926

2

0.04

Roscommon, Ireland
(1990)

50+

2186

2

0.01

Mamre, South Africa
(1992)

40+

987

23

2.30

Japan
(1988–1989)

40+

8126

28

0.34

Doumen, China
(1990)

45+

932

6

0.64

Mongolia
(1995)

40+

942

14

1.40

Alaskan Inuit
(1985)

40+

377

10

2.65

Copenhagen, Inuit women
(1978)

40+

63

2

3.20

Greenland Inuit
(1969)

40+

344

21

6.10

  

TABLE 4

Prevalence of primary angle-closure glaucoma by age and sex

Study
(Year)

Age

Prevalence (%)

Men

Women

Mongolia
(1995)

40–49

0.0

0.8

50–59

0.8

1.3

60–69

2.5

4.9

70+

7.5

0.0

Japan

(1988-1989)



40+

1.5

1.5

30–49

0.0

0.0

50–69

0.17

0.49

70+

0.70

0.85

Mamre, South Africa (1992)

30+

0.21

0.38

40–49

0.0

1.5

50–59

1.0

0.7

60–69

2.3

5.2

70+

2.3

11.9

Alaskan Inuit (1986–1987)

40+

1.0

3.2

<50

0.0

0.0

50–59

3.1

3.6

60–69

2.6

11.8

70+

3.7

11.8

Alaskan Inuit
(1985)

40+

2.1

5.5

50+

0.24

0.94

Greenland Inuit
(1969)

40+

1.9

9.9

Doumen, China
(1990)

45+

0.3

0.3

  

TABLE 5

Estimated ratio of primary open-angle
glaucoma to primary angle-closure glaucoma
by race

Racial origin

Ratio

China

2:3

India

1:1

South Asia

1:1

Europe

11:1

Africa

152:1

Latin America

2:1

Near East

2:1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 1

Estimated Age, Gender, and Race/Ethnicity Specific Prevalence Rates (%)

For Open-Angle Glaucoma in the U.S.

Source: www.nei.nih.gov/eyedata/tables.htm

 

REFERENCES

 

1. Alsbirk PH. Primary angle-closure glaucoma: oculometry, epidemiology and genetics in a high-risk population. Acta Ophthalmol 1976;54:–31.

 

2. Arkell SM, Lightman DA, Sommer A, et al. The prevalence of glaucoma among Eskimos of NW Alaska. Arch Ophthalmol 1987;105:482–5.

 

3. Bonomi L, Marchini G, Marraffa M et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population: the Egna-Neumarkt Study. Ophthalmology 1998;105:209-215.

4. Cedrone C, Culasso F, Cesareo M, Zapelloni A, Cedrone P, Cerulli L. Prevalence of glaucoma in Ponza, Italy: a comparison with other studies. Ophthalmic Epidemiol 1997;4:59–72.

 

5. Coffey M, Reidy A, Wormald R, Xian WX, Wright L, Courtney P. Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol 1993;77:17–21.

 

6. Congdon N, Wang F, Tielsch JM. Issues in the epidemiology and population-based screening of primary angle-closure glaucoma. Surv Ophthalmol 1992;36:411–23.

 

7. Dandona L, Dandona R, Mandal P, et al. Angle closure glaucoma in an urban population in southern India: the Andhra Pradesh eye disease study. Ophthalmology 2000;107:1710-1716.

 

8. Dandona L, Dandona R, Srinivas M, et al. Open-angle glaucoma in an urban population in southern India: the Andhra Pradesh eye disease study. Ophthalmology 2000;107:1702-1709.

 

9. Dielemans I, Vingerling JR, Wolfs RC et. al. The prevalence of primary open angle glaucoma in a population-based study in the Netherlands: the Rotterdam Eye Study. Ophthalmology 1994;101:1851-1855.

 

10. Erie JC, Hodge DO, Gray DT. The incidence of primary angle-closure glaucoma in Olmsted County, Minnesota. Arch Ophthalmol 1997;115:177–81.

 

11. Foster PJ, Baasanhu J, Alsbirk PH, Munkhbayar D, Uranchimeg D, Johnson GJ. Glaucoma in Mongolia: a population-based survey in Hovsgol Province, Northern Mongolia. Arch Ophthalmol 1996;114:1235–41.

 

12. Foster PJ, Johnson GJ. Glaucoma in China:How big is the problem? Br J Ophthalmol 2001;85:1277-1282.

 

13. Giuffre G, Giammanco R, Dardanoni G, Ponte F. Prevalence of glaucoma and distribution of intraocular pressure in a population. The Casteldaccia Eye Study. Acta Ophthalmol Scand 1995;73:222–5.

 

14. Hattenhauer MG, Johnson DH, Ing HH et al. The probability of blindness from open-angle glaucoma. Ophthalmology 1998;105:2099-2104.

 

15. Hiller R, Kahn HA. Blindness from glaucoma. Am J Ophthalmol 1975;80:62–9.

 

16. Kahn HA, Leibowitz HM, Gangley J, et al. The Framingham Eye Study. I: Outline and major prevalence findings. Am J Epidemiol 1977;106:17–32.

 

17. Kahn HA, Milton RC. Alternative definitions of open-angle glaucoma. Effect on prevalence and associations in the Framingham Eye Study. Arch Opthalmol 1980;98:2172–7.

 

18. Kini MM, Leibowitz HM, Colton T, Nickerson RJ, Gangley J, Dawber TR. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham Eye Study. Am J Ophthalmol 1978;85:28–34.

 

19. Kitazawa Y. Epidemiology of PACG. Asian Pac J Ophthalmol 1990;2:78–81.

 

20. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992;99:1499–504.

 

21. Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 1994;112:821–9.

 

22. Leske MC. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol 1983;118:166–91.

 

23. Mason RP, Omofolasade K, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I: prevalence findings. Ophthalmology 1989;96:1363–8.

 

24. Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:1661–9.

 

25. Nguyen N, Mora JS, Gaffney MM, et al. A high prevalence of occludable angles in a Vietnamese population. Ophthalmology 1996;103:1426–31.

 

26. Quigley HA, West SK, Rodriguez J, et al. The prevalence of glaucoma in a population-based study of Hispanic subjects. Proyecto VER. Arch Ophthalmol 2001;119:1819-1826.

 

27. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthal 1996;80:389–93.

28. Salmon JF, Mermoud A, Ivey A, Swanevelder SA, Hoffman M. The prevalence of primary angle-closure glaucoma and open angle glaucoma in Mamre, western Cape, South Africa. Arch Ophthalmol 1993;111:1263–9.

 

29. Shiose Y, Kitazawa Y, Tsukahara S, et al. Epidemiology of glaucoma in Japan—a nationwide glaucoma survey. Jpn J Ophthalmol 1991;35:133–55.

 

30. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in East Baltimore. N Engl J Med 1991;325:1412–7.

 

31. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991;266:369–74.

 

32. van Rens GHMB, Arkell SM, Charlton W, Doesburg W. Primary angle-closure glaucoma among Alaskan Eskimos. Documenta Ophthalmologica 1988;70:265–76.

 

33. Wensor MD, McCarty CA Stanislavsky YL, Liningston PM, Taylor HR. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology 1998;105:733-739.

 

34. Yu Q, Xu J, Zhu S, Liu Q. Epidemiological survey of primary angle-closure glaucoma in Doumen. Yen Ko Hsueh Pao 1995;11:5–8.

 

 

Back

Hit back button to return to the previous page.

 

 

Copyright © 2010 Glaucoma Service Foundation to Prevent Blindness

 

Disclaimer / Privacy Statement